Este medicamento puede causar efectos secundarios, como nuseas/vmitos, cambios en los movimientos intestinales, como diarrea o estreimiento, dolor abdominal, dolor de cabeza y fatiga
The review's conclusion: Health Canada did not find evidence to support a link between GLP-1 RAs and the risks of suicide, self-harm and suicidal/self-harm ideation in patients with type 2 diabetes, but there was not enough information to determine if there is a link in patients with obesity
We need a hero in obesity care today, said Fitch, founder and chief medical officer of knownwell, a weight-loss and medical care company
J., Vieth, R., Umhau, J
Furthermore, GLP-1R activation activates the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway via G-protein coupled receptor subunits (Fletcher et al